These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 30737462)

  • 1. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.
    Butterfield DA; Halliwell B
    Nat Rev Neurosci; 2019 Mar; 20(3):148-160. PubMed ID: 30737462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, protein modification and Alzheimer disease.
    Tramutola A; Lanzillotta C; Perluigi M; Butterfield DA
    Brain Res Bull; 2017 Jul; 133():88-96. PubMed ID: 27316747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia.
    Bryll A; Skrzypek J; Krzyściak W; Szelągowska M; Śmierciak N; Kozicz T; Popiela T
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32121669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA
    Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.
    Butterfield DA; Lange ML
    J Neurochem; 2009 Nov; 111(4):915-33. PubMed ID: 19780894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in the progression of Alzheimer's disease.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2010; 19(1):341-53. PubMed ID: 20061649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
    Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
    Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.
    Griffith CM; Macklin LN; Cai Y; Sharp AA; Yan XX; Reagan LP; Strader AD; Rose GM; Patrylo PR
    J Alzheimers Dis; 2019; 68(2):809-837. PubMed ID: 30775979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases.
    Butterfield DA
    J Alzheimers Dis; 2018; 64(s1):S469-S479. PubMed ID: 29504538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional Glucose Metabolism in Alzheimer's Disease Onset and Potential Pharmacological Interventions.
    Kumar V; Kim SH; Bishayee K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies for Alzheimer's disease: a metabolic perspective.
    Domingues R; Pereira C; Cruz MT; Silva A
    Mol Genet Metab; 2021 Mar; 132(3):162-172. PubMed ID: 33549409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.
    Rummel NG; Butterfield DA
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1289-1305. PubMed ID: 34416829
    [No Abstract]   [Full Text] [Related]  

  • 17. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary-challenged mice with Alzheimer-like pathology show increased energy expenditure and reduced adipocyte hypertrophy and steatosis.
    Schreyer S; Berndt N; Eckstein J; Mülleder M; Hemmati-Sadeghi S; Klein C; Abuelnor B; Panzel A; Meierhofer D; Spranger J; Steiner B; Brachs S
    Aging (Albany NY); 2021 Apr; 13(8):10891-10919. PubMed ID: 33864446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.